BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28743492)

  • 1. 5-Bromoindirubin 3'-(O-oxiran-2-ylmethyl)oxime: A long-acting anticancer agent and a suicide inhibitor for epoxide hydrolase.
    Ichimaru Y; Fujii T; Saito H; Sano M; Uchiyama T; Miyairi S
    Bioorg Med Chem; 2017 Sep; 25(17):4665-4676. PubMed ID: 28743492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirubin 3'-(O-oxiran-2-ylmethyl)oxime: a novel anticancer agent.
    Ichimaru Y; Saito H; Uchiyama T; Metori K; Tabata K; Suzuki T; Miyairi S
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1403-6. PubMed ID: 25765906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
    Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
    Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of indirubin analogues as phosphorylase kinase inhibitors.
    Begum J; Skamnaki VT; Moffatt C; Bischler N; Sarrou J; Skaltsounis AL; Leonidas DD; Oikonomakos NG; Hayes JM
    J Mol Graph Model; 2015 Sep; 61():231-42. PubMed ID: 26364215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, structure, in vitro cytotoxic activity evaluation and docking studies on target enzyme GSK-3β of new indirubin-3'-oxime derivatives.
    Dan NT; Quang HD; Van Truong V; Huu Nghi D; Cuong NM; Cuong TD; Toan TQ; Bach LG; Anh NHT; Mai NT; Lan NT; Van Chinh L; Quan PM
    Sci Rep; 2020 Jul; 10(1):11429. PubMed ID: 32651416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5,5'-substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity.
    Choi SJ; Lee JE; Jeong SY; Im I; Lee SD; Lee EJ; Lee SK; Kwon SM; Ahn SG; Yoon JH; Han SY; Kim JI; Kim YC
    J Med Chem; 2010 May; 53(9):3696-706. PubMed ID: 20361800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirubin 3'-oxime inhibits anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells.
    Tanaka T; Ohashi S; Saito H; Wada T; Aoyama T; Ichimaru Y; Miyairi S; Kobayashi S
    Biochem Biophys Res Commun; 2018 Jan; 496(1):7-11. PubMed ID: 29274785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water-soluble cationic derivatives of indirubin, the active anticancer component from Indigo naturalis.
    Ginzinger W; Egger A; Mühlgassner G; Arion VB; Jakupec MA; Galanski M; Berger W; Keppler BK
    Chem Biodivers; 2012 Oct; 9(10):2175-85. PubMed ID: 23081917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel indirubin-3'-monoxime derivatives as potent inhibitors against CDK2 and CDK9.
    Yan L; Lai F; Chen X; Xiao Z
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2447-51. PubMed ID: 25908517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor.
    Nisha CM; Kumar A; Vimal A; Bai BM; Pal D; Kumar A
    J Mol Graph Model; 2016 Apr; 65():100-7. PubMed ID: 26967552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism responsible for inhibitory effect of indirubin 3'-oxime on anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells.
    Tanaka T; Kasai M; Kobayashi S
    Exp Cell Res; 2018 Sep; 370(2):454-460. PubMed ID: 29981748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and antitumor activity evaluation of steroidal oximes.
    Gomes AR; Pires AS; Abrantes AM; Gonçalves AC; Costa SC; Varela CL; Silva ET; Botelho MF; Roleira FMF
    Bioorg Med Chem; 2021 Sep; 46():116360. PubMed ID: 34425478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antiproliferative activity of 7-azaindirubin-3'-oxime, a 7-aza isostere of the natural indirubin pharmacophore.
    Kritsanida M; Magiatis P; Skaltsounis AL; Peng Y; Li P; Wennogle LP
    J Nat Prod; 2009 Dec; 72(12):2199-202. PubMed ID: 19994845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The indirubin derivative 6-bromoindirubin-3'-glycerol-oxime ether (6BIGOE) potently modulates inflammatory cytokine and prostaglandin release from human monocytes through GSK-3 interference.
    Czapka A; König S; Pergola C; Grune C; Vougogiannopoulou K; Skaltsounis AL; Fischer D; Werz O
    Biochem Pharmacol; 2020 Oct; 180():114170. PubMed ID: 32710971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells.
    Kameswaran TR; Ramanibai R
    Biomed Pharmacother; 2009 Feb; 63(2):146-54. PubMed ID: 18450412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel steroidal 5α,8α-epidioxyandrost-6-ene-3β-ol-17-(O-phenylacetamide)oxime derivatives as potential anticancer agents.
    Bu M; Cao T; Li H; Guo M; Yang BB; Zeng C; Zhou Y; Zhang N; Hu L
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3856-3861. PubMed ID: 28666736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis.
    Xingi E; Smirlis D; Myrianthopoulos V; Magiatis P; Grant KM; Meijer L; Mikros E; Skaltsounis AL; Soteriadou K
    Int J Parasitol; 2009 Oct; 39(12):1289-303. PubMed ID: 19445946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirubin-3-Oxime Effectively Prevents 6OHDA-Induced Neurotoxicity in PC12 Cells via Activating MEF2D Through the Inhibition of GSK3β.
    Hu S; Cui W; Zhang Z; Mak S; Xu D; Li G; Hu Y; Wang Y; Lee M; Tsim KW; Han Y
    J Mol Neurosci; 2015 Dec; 57(4):561-70. PubMed ID: 26346600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins.
    Myrianthopoulos V; Magiatis P; Ferandin Y; Skaltsounis AL; Meijer L; Mikros E
    J Med Chem; 2007 Aug; 50(17):4027-37. PubMed ID: 17665890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons.
    Martin L; Magnaudeix A; Wilson CM; Yardin C; Terro F
    J Neurosci Res; 2011 Nov; 89(11):1802-11. PubMed ID: 21826701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.